What if we could prevent expensive, debilitating diseases such as diabetes or kidney disease instead of treating them? Or cure cancer instead of battling it? Ryan Hutchinson, a Portfolio Manager/Analyst on our Digital Health strategy, tells host Ron Temple why he believes an explosion in the availability and quality of biological data is about to transform the health care industry, with vast implications for both established players and newcomers. Or, as he put it, why he believes the large pharmaceutical companies of the future are in the incubation stage today.